SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007157
Filing Date
2019-05-15
Accepted
2019-05-14 20:07:18
Documents
56
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 605409
2 ex31-1.htm EX-31.1 13999
3 ex31-2.htm EX-31.2 14075
4 ex32.htm EX-32 5172
  Complete submission text file 0001493152-19-007157.txt   3796123

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE brtx-20190331.xml EX-101.INS 602722
6 XBRL SCHEMA FILE brtx-20190331.xsd EX-101.SCH 62381
7 XBRL CALCULATION FILE brtx-20190331_cal.xml EX-101.CAL 47666
8 XBRL DEFINITION FILE brtx-20190331_def.xml EX-101.DEF 219800
9 XBRL LABEL FILE brtx-20190331_lab.xml EX-101.LAB 382597
10 XBRL PRESENTATION FILE brtx-20190331_pre.xml EX-101.PRE 282715
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 19824691
SIC: 8090 Services-Misc Health & Allied Services, NEC